NewYorkBIO in the News
May 2, 2016
By Nathan Tinker, Executive Director, NewYorkBIO
"Elected officials in Albany and Washington are falling over each other to prove who is going to "drive down" the costs of prescription drugs. But they are missing a key point: innovative biopharmaceuticals reduce overall health care costs and improve the lives of millions of people every day. . . ."
March 9, 2016
... "This isn’t the time to be trying to pass this type of legislation in New York,” said Nathan Tinker, Executive Director of NewYorkBIO. "With the uncertainty around the Vermont legislation, and a likely federal solution to the issue, our lawmakers should focus on issues that will have a positive impact and not on mandates that send a negative message about the value we place on science and the biotech industry in our state.” ...
December 18, 2015
May 18, 2015
... The recent push to attach warning labels to any food product that has been modified by modern genetic engineering techniques is simply bad policy - it purposefully ignores decades of research and will set New York apart as newly and uniquely hostile to scientific consensus . . .
May 5, 2015
... A theme emerged that permeated the meeting, which brought together the entrepreneurs, investors, government agencies, and others on the front lines of life sciences in New York: this is a boostrapping biotech community, and it has to be to claw its way forward. . . .
May 15, 2014
... According to Nathan Tinker, Executive Director of New York BIO, the City is replete with skilled workers in the biotech industry, 79,000 at last count. But what is lacking, according to him, are the serial entrepreneurs who are essential to building a large and robust biotech community. This is an experience level that no one else can replace." ...
February 4, 2013